Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Irina G. Rekhtina"'
Autor:
Irina G. Rekhtina, Victoria A. Khyshova, Nadezhda I. Zozulya, Valentina N. Dvirnyk, Larisa P. Mendeleyeva
Publikováno v:
Терапевтический архив, Vol 95, Iss 9, Pp 746-750 (2023)
Aim. To analyze the frequency and nature of hemorrhagic and thrombotic complications in patients with systemic AL-amyloidosis and compare with laboratory changes in the hemostasis system. Materials and methods. The prospective study included 40 pa
Externí odkaz:
https://doaj.org/article/26adafdf0ba8425b9a2a4b45f43ce5e5
Autor:
Irina G. Rekhtina, Larisa P. Mendeleeva, Natalia P. Soboleva, Irina A. Dubina, Margarita Iu. Pervakova, Sergey V. Lapin
Publikováno v:
Терапевтический архив, Vol 94, Iss 1, Pp 135-144 (2022)
Paraprotein is a laboratory biomarker of plasma cell tumors and other lymphoproliferative diseases. Its determination is necessary for diagnosing, monitoring and assessment of therapy effectiveness. The lecture presents the main methods of qualitativ
Externí odkaz:
https://doaj.org/article/bb533588785a457d9e1905df8bb28b28
Autor:
Larisa P. Mendeleeva, Olga M. Votiakova, Irina G. Rekhtina, Evgenii A. Osmanov, Irina V. Poddubnaya, Liudmila Iu. Grivtsova, Natalia A. Falaleeva, Vadim V. Baikov, Alla M. Kovrigina, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian
Publikováno v:
Современная онкология, Vol 22, Iss 4, Pp 6-28 (2021)
Multiple myeloma
Externí odkaz:
https://doaj.org/article/26aa1c3ad2d043418a72f9f31ef3b5f4
Autor:
Elena Zakharova, Olga A Vorobyeva, Ekaterina S Stolyarevich, Irina G. Rekhtina, Tatyana A Makarova
Publikováno v:
Journal of Onco-Nephrology. 4:59-63
Introduction: According to the recent International Kidney and Monoclonal Gammopathy Research Group Consensus report, the spectrum of monoclonal gammopathies of renal significance merges more than 12 conditions; and combinations of various patterns o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa19e9f862d599b79d9bbea1a462cb34
https://doi.org/10.1177/2399369320916467
https://doi.org/10.1177/2399369320916467
Autor:
Irina G. Rekhtina, Evgeniia V. Kazarina, Larisa P. Mendeleeva, Alla M. Kovrigina, Ekaterina S Stolyarevich, V N Dvirnyk, Valeriy G. Savchenko, Sergei M. Kulikov
Publikováno v:
Blood. 136:39-40
Introduction: Myeloma cast nephropathy (MCN) is a main cause of acute kidney injury (AKI) at multiple myeloma (MM) onset. Wherein 5-9% of newly diagnosed MM patients are dialysis dependent. The introduction of novel agents has provided the achievemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea7b59d01768c53c339293b139f8d8f5
https://doi.org/10.1182/blood-2020-133324
https://doi.org/10.1182/blood-2020-133324
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 1, Pp OD12-OD13 (2018)
Cases of Immunotactoid Glomerulopathy (ITG) in patients with Multiple Myeloma (MM) are extremely rare. Consequently, data on efficacy and therapy results are limited. We report on a rare case of long-term follow up patient with MM and ITG. After chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::810984d920ecc84467bfda5aba27b255
Autor:
Irina G. Rekhtina, Dorzho B. Ayusheev, Ruzanna A. Ovsepyan, Elena N. Lipets, Elena I. Sinauridze, Fazoil I. Ataullakhanov, Alex I. Bernakevich, Irina V. Gribkova
Publikováno v:
Scientific Reports
A new oral anticoagulant, dabigatran etexilate (DE, a prodrug of direct thrombin inhibitor (DTI) dabigatran), has been used clinically to prevent thrombosis. The assessment of dabigatran efficiency is necessary in some clinical cases, such as renal i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26079755ec20a349299bd49af1bb42af
https://doi.org/10.1038/srep29242
https://doi.org/10.1038/srep29242
Autor:
Olga S. Pokrovskaya, Larisa P. Mendeleeva, Valery G. Savchenko, Maiia V. Firsova, Eduard G. Gemdzhian, Irina G. Rekhtina, L S Biryukova, Maxim V. Solovev
Publikováno v:
Blood. 132:5765-5765
Introduction. Multiple myeloma (MM) in its early onset is complicated by myeloma nephropathy in 20-30% of patients, 10% of whom require haemodialysis. Early studies have shown that renal dysfunction has no adverse effect on melphalan pharmacokinetics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df349f13c4c5faa41e4df4297fcf37a
https://doi.org/10.1182/blood-2018-99-115880
https://doi.org/10.1182/blood-2018-99-115880
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 1, Pp OD12-OD13 (2018)
Cases of Immunotactoid Glomerulopathy (ITG) in patients with Multiple Myeloma (MM) are extremely rare. Consequently, data on efficacy and therapy results are limited. We report on a rare case of long-term follow up patient with MM and ITG. After chem
Externí odkaz:
https://doaj.org/article/f5440563ff2142e7b24987b814270543